Back

Intra-Cellular Therapies Stock Predictions

Sell

ITCI
Intra-Cellular Therapies

Last Price:

65.29

Seasonality Move:

-0.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 28.3% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $65.00. The Score for ITCI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 28.3% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

84.89

52-Week Low:

45.50

Prediction Charts

Market Cap:

6.86B

Price in USD:

65.00

Volume:

767.79K

Beta:

1.10

Technical Analysis

SMA50:

68.71

SMA100:

69.15

SMA200:

62.77

52-Wk Change:

2.51%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 65.00 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-30	72.45	71.80	72.83	71.38
May-1	71.61	72.67	73.68	71.61
May-2	73.77	70.34	73.77	69.98
May-3	71.07	68.80	71.35	68.48
May-6	68.88	70.96	71.02	68.26
May-7	69.72	71.21	71.64	68.61
May-8	71.12	67.00	71.22	66.95
May-9	66.97	65.53	67.23	65.45
May-10	65.75	64.96	66.71	64.92
May-13	65.16	66.32	67.22	65.16
May-14	66.76	65.71	67.27	65.17
May-15	66.68	66.84	68.16	66.51
May-16	66.72	66.53	67.10	65.51
May-17	66.88	65.00	66.88	64.92

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.44 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.